We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 384

Intellectual Property Weekly Abstracts Bulletin Week of July 10, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • July 12 2017

Motion on additional read-ins allowed in part; hearsay excluded Excalibre Oil Tools Ltd. v. Advantage Products Inc., 2016 FC 1130 In this patent


Motion for default judgment denied without affidavit evidence
  • Borden Ladner Gervais LLP
  • Canada
  • October 28 2013

The Plaintiffs brought a motion for default judgment after no Statement of Defence was filed and no response to the Request to Admit was provided. The


Re-examination process stayed pending resolution of patent infringement action
  • Borden Ladner Gervais LLP
  • Canada
  • June 28 2017

In this motion, Camso requested a stay of a request made by a law firm, Brouillette Partners, to the Commissioner of Patents to re-examine one of


Motion for bifurcation of liability issues, as well as counterclaim for section 8 damages, dismissed
  • Borden Ladner Gervais LLP
  • Canada
  • July 3 2017

The Court dismissed the Plaintiffs’ motion for a bifurcation order requesting that liability issues in this infringement action be tried separately


Supreme Court of Canada invalidates the promise doctrine
  • Borden Ladner Gervais LLP
  • Canada
  • July 3 2017

In this decision, the Supreme Court of Canada (SCC) overturned the decision of the Federal Court of Appeal (FCA), and held the patent to be valid and


Federal Court Reissues its Original Decision to Award Section 8 Damages After the Federal Court of Appeal Held the Original Decision Relied on Inadmissible Hearsay Evidence
  • Borden Ladner Gervais LLP
  • Canada
  • June 7 2017

The Federal Court has reaffirmed and reissued its original decision awarding section 8 damages to Teva following a redetermination that was ordered by


Documents included in joint book for trial should be exhibits for appeal
  • Borden Ladner Gervais LLP
  • Canada
  • June 11 2012

The issue to be determined relates to the contents of the appeal books


Formulation patent found not to be infringed as a redacted excipient was not a “pentahydric or hexahydric alcohol”
  • Borden Ladner Gervais LLP
  • Canada
  • April 22 2015

Apotex has successfully alleged that Teva’s patent to “Stable Compositions Containing Rasagiline” will not be infringed by Apotex’s use of a


Court dismisses motion for Confidentiality Order
  • Borden Ladner Gervais LLP
  • Canada
  • May 18 2017

The Court dismissed Teva's motion for a confidentiality order. The underlying proceeding is an action by Teva to recover from Janssen and others


The Court grants an innovator standing and the right to be made a party in a judicial Review of the Minister’s Decision relating to the application of the data protection regime
  • Borden Ladner Gervais LLP
  • Canada
  • April 26 2014

This was a motion that raised the issue of an innovator’s standing and right to be made a party to a judicial review of the Minister of Health’s